Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-08-001798
Filing Date
2008-03-14
Accepted
2008-03-14 16:50:16
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 IDENIX PHARMACEUTICALS, INC. FORM 10-K b68136ipe10vk.htm 10-K 1365752
2 EX-3.4 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION b68136ipexv3w4.htm EX-3.4 4662
3 EX-21.1 SUBSIDIARIES OF THE COMPANY b68136ipexv21w1.htm EX-21.1 3845
4 EX-23.1 CONSENT OF PRICEWATERHOUSECOOPERS LLP b68136ipexv23w1.htm EX-23.1 1342
5 EX-31.1 SECTION 302 CERTIFICATION OF CEO b68136ipexv31w1.htm EX-31.1 5878
6 EX-31.2 SECTION 302 CERTIFICATION OF CFO b68136ipexv31w2.htm EX-31.2 6132
7 EX-32.1 SECTION 906 CERTIFICATION OF CEO b68136ipexv32w1.htm EX-32.1 3807
8 EX-32.2 SECTION 906 CERTIFICATION OF CFO b68136ipexv32w2.htm EX-32.2 3537
  Complete submission text file 0000950135-08-001798.txt   1396408
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET . CAMBRIDGE MA 02139 (617) 250-3100
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

EIN.: 450478605
Type: 10-K | Act: 34 | File No.: 000-49839 | Film No.: 08690053
SIC: 2834 Pharmaceutical Preparations